In last trading session, Revelation Biosciences Inc (NASDAQ:REVB) saw 0.3 million shares changing hands with its beta currently measuring 0.18. Company’s recent per share price level of $3.77 trading at -$0.05 or -1.31% at ring of the bell on the day assigns it a market valuation of $1.97M. That closing price of REVB’s stock is at a discount of -4950.4% from its 52-week high price of $190.40 and is indicating a premium of 11.41% from its 52-week low price of $3.34. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.23 million shares which gives us an average trading volume of 236.15K if we extend that period to 3-months.
For Revelation Biosciences Inc (REVB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -10.32 in the current quarter.
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Upright in the red during last session for losing -1.31%, in the last five days REVB remained trading in the red while hitting it’s week-highest on Wednesday, 01/29/25 when the stock touched $3.77 price level, adding 19.79% to its value on the day. Revelation Biosciences Inc’s shares saw a change of -48.89% in year-to-date performance and have moved -4.06% in past 5-day. Revelation Biosciences Inc (NASDAQ:REVB) showed a performance of -38.81% in past 30-days. Number of shares sold short was 45861.0 shares which calculate 0.11 days to cover the short interests.
Revelation Biosciences Inc (REVB) estimates and forecasts
Statistics highlight that Revelation Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -85.72% of value to its shares in past 6 months, showing an annual growth rate of 79.76% while that of industry is 16.00. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
In 2025, company’s earnings growth rate is likely to be around -1311.32% while estimates for its earnings growth in next 5 years are of -23.98%.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
Insiders are in possession of 0.03% of company’s total shares while institution are holding 11.37 percent of that, with stock having share float percentage of 11.37%. Investors also watch the number of corporate investors in a company very closely, which is 11.37% institutions for Revelation Biosciences Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 501.0 shares of worth $1888.0 or 0.01% of the total outstanding shares. The later fund manager was in possession of 184.0 shares on Oct 31, 2024 , making its stake of worth around $693.0 in the company or a holder of 0.00% of company’s stock.
